Clinical trial: The efficacy and safety of oral PF-03491390, a pancaspase inhibitor - A randomized placebo-controlled study in patients with chronic hepatitis C

M. L. Shiffman, P. Pockros, J. G. McHutchison, E. R. Schiff, M. Morris, G. Burgess

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Fingerprint Dive into the research topics of 'Clinical trial: The efficacy and safety of oral PF-03491390, a pancaspase inhibitor - A randomized placebo-controlled study in patients with chronic hepatitis C'. Together they form a unique fingerprint.

Medicine & Life Sciences